Literature DB >> 15733231

A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development.

Maurizio Rocchetti1, Italo Poggesi, Massimiliano Germani, Francesco Fiorentini, Cinzia Pellizzoni, Paola Zugnoni, Enrico Pesenti, Monica Simeoni, Giuseppe De Nicolao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15733231     DOI： 10.1111/j.1742-7843.2005.pto960325.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN： 1742-7835            Impact factor:   4.080


× No keyword cloud information.
  9 in total

1.  Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice.

Authors:  Nelson L Jumbe; Yan Xin; Douglas D Leipold; Lisa Crocker; Debra Dugger; Elaine Mai; Mark X Sliwkowski; Paul J Fielder; Jay Tibbitts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-28       Impact factor: 2.745

2.  Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice.

Authors:  Giulia Lestini; France Mentré; Paolo Magni
Journal:  AAPS J       Date:  2016-06-15       Impact factor: 4.009

3.  A pharmacokinetic-pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055.

Authors:  James W T Yates; Sarah V Holt; Armelle Logie; Kirsty Payne; Karen Woods; Robert W Wilkinson; Barry R Davies; Sylvie M Guichard
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

4.  Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems.

Authors:  Jun Yang; Donald E Mager; Robert M Straubinger
Journal:  AAPS J       Date:  2009-11-10       Impact factor: 4.009

5.  Modeling of tumor growth and anticancer effects of combination therapy.

Authors:  Gilbert Koch; Antje Walz; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-22       Impact factor: 2.745

6.  Mathematical model of tumor volume dynamics in mice treated with electrochemotherapy.

Authors:  Tadeja Forjanič; Damijan Miklavčič
Journal:  Med Biol Eng Comput       Date:  2016-09-22       Impact factor: 2.602

7.  A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination.

Authors:  Nadia Terranova; Massimiliano Germani; Francesca Del Bene; Paolo Magni
Journal:  Cancer Chemother Pharmacol       Date:  2013-06-29       Impact factor: 3.333

Review 8.  Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

Authors:  Stephan Herbertz; J Scott Sawyer; Anja J Stauber; Ivelina Gueorguieva; Kyla E Driscoll; Shawn T Estrem; Ann L Cleverly; Durisala Desaiah; Susan C Guba; Karim A Benhadji; Christopher A Slapak; Michael M Lahn
Journal:  Drug Des Devel Ther       Date:  2015-08-10       Impact factor: 4.162

Review 9.  How Should Cancer Models Be Constructed?

Authors:  Robert A Beckman; Irina Kareva; Frederick R Adler
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.